Corrects company ticker symbol in first bullet and header field
** Shares of investment management co Challenger CGF.AX drop as much as 8.8% to A$5.59, their lowest levels since January 28, 2022
** Co posts HY normalised NPAT of A$225 million ($142.94 million), lower than consensus estimate of A$229 million, according to Jefferies
** Total sales for co's core Life segment fall 12% in HY; Life normalised EBIT misses expectations
** Declares interim dividend of 14.5 Australian cents per share, higher than consensus estimates of 13.8 cents
** CGF stock is worst performer on ASX 200 benchmark index .AXJO
** Stock down 4.7% YTD, including day's moves
($1 = 1.5741 Australian dollars)
(Reporting by Himanshi Akhand in Bengaluru)
((Himanshi.Akhand@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。